Illumina, Inc. (NASDAQ:ILMN – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Wednesday after Morgan Stanley lowered their price target on the stock from $150.00 to ...

We recently published a list of Jim Cramer Discusses These 10 Stocks & Dissects President Trump’s China Tariffs. In this ...

Illumina (NASDAQ:ILMN – Get Free Report) was downgraded by investment analysts at Barclays from an “equal weight” rating to ...

However, 10 companies defied a broader market optimism, mostly due to a series of stock rating downgrades from investment ...

On Monday, for the second time in as many business days, Illumina (NASDAQ: ILMN) stock took it on the chin because of an ...

What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) fell 7.5% in the morning session after Barclays downgraded ...

Illumina (NASDAQ:ILMN) has been cut to underweight from equal weight by Barclays over concerns the company may be facing sanctions in China and risks to its 2025 and long-range guidance. "Given our ...

Illumina (NASDAQ:ILMN – Free Report) had its price objective cut by Canaccord Genuity Group from $145.00 to $135.00 in a report published on Friday,Benzinga reports. They currently have a hold rating ...

The general mood among these heavyweight investors is divided, with 37% leaning bullish and 37% bearish. Among these notable options, 4 are puts, totaling $366,099, and 4 are calls, amounting to ...

Barclays downgraded Illumina Inc (NASDAQ:ILMN) to "Underweight" given growing uncertainty in China, rising competition from Roche in the clinical market, and weaker-than-expected elasticity in ...

We recently compiled a list of the These 10 Firms Were Last Week’s Worst Performers. In this article, we are going to take a ...

Bruker shares fell by 2.5%, Illumina by 3.3%, Quanterix by 2.8%, Bio-Techne by 5%, 10X Genomics by 8.8%, and Qiagen by 3.5%. Analysts have noted that this move by the NIH could have a material impact ...